Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Structure-based classification of EGFR mutations informs inhibitor selection for lung cancer therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Structure-based classification of EGFR mutations informs inhibitor selection for lung cancer therapy.
Structure-based classification of EGFR mutations informs inhibitor selection for lung cancer therapy. Cancer Cell. 2021 11 08; 39(11):1455-1457.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
ErbB Receptors
Humans
Lung Neoplasms
Mutation
authors with profiles
Ralf Kittler